Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
AstraZeneca: Dividend Dynamo or Blowup?
Motley Fool
Sat, 06/25/11 - 08:59 pm
AstraZeneca
Bristol-Myers Experimental Diabetes Drug Safe After 2 Years, Study Shows
Bloomberg
Sat, 06/25/11 - 08:44 pm
Bristol-Myers Squibb
AstraZeneca
AstraZeneca: Rich Dividend Yield, But Pipeline, Earnings Challenges on the Horizon
Seeking Alpha
Fri, 06/24/11 - 09:11 am
AstraZeneca
pipelines
earnings
dividends
AstraZeneca sells its med tech arm to Dentsply for $1.8 billion in cash | Deals Roundup
Thu, 06/23/11 - 06:14 pm
AstraZeneca
Dentsply
Bristol-Myers Diabetes Drug Draws Scrutiny After Avandia, Actos
Bloomberg
Thu, 06/23/11 - 09:12 am
Avandia
diabetes
Bristol-Myers Squibb
Actos
Takeda
AstraZeneca
Dapagliflozin
DENTSPLY International Announces Agreement to Acquire Astra Tech from AstraZeneca
Wed, 06/22/11 - 09:33 pm
Dentsply
AstraZeneca
Astra Tech
M&A
AstraZeneca sells dental business to Dentsply for $1.8 billion
Yahoo/AP
Wed, 06/22/11 - 08:11 am
Dentsply
M&A
AstraZeneca
Astra Tech
High Doses of Cholesterol Drugs Raise Diabetes Risk in Study
Bloomberg
Tue, 06/21/11 - 09:53 pm
diabetes
Pfizer
AstraZeneca
statins
Crestor
Lipitor
Best Healthcare Sector Dividend Stocks
Seeking Alpha
Tue, 06/21/11 - 09:48 pm
dividends
AstraZeneca
Bristol-Myers Squibb
Trinity Biotech
AstraZeneca Near Sale of Unit to Dentsply
Tue, 06/21/11 - 12:07 pm
AstraZeneca
Dentsply
Dentsply in talks to buy AstraZeneca unit - source
Reuters
Tue, 06/21/11 - 10:49 am
Dentsply
AstraZeneca
M&A
dental implants
Astra Tech
AstraZeneca veteran Nicklasson named to Pozen’s board
MedCity News
Sat, 06/18/11 - 10:44 am
AstraZeneca
Pozen
When Two Cancer Drugs Are Better Than One
Bloomberg Businessweek
Fri, 06/17/11 - 10:17 am
Merck
AstraZeneca
Eli Lilly
Roche
GSK
Takeda
cancer
Bristol-Myers Squibb
Off a Cliff: $100 Billion in Revenues Will Disappear From Drug Business by 2013
BNET Pharma
Thu, 06/16/11 - 12:29 pm
patents
generics
Pfizer
Eli Lilly
Bristol-Myers Squibb
GSK
Novartis
AstraZeneca
Merck
Sanofi
JNJ
Forest Labs
AstraZeneca Grabs Russian Opportunity
WSJ Online
Thu, 06/16/11 - 10:51 am
Russia
AstraZeneca
Merck With AstraZeneca Leads Rivals-Turned-Allies in Cancer
Bloomberg
Wed, 06/15/11 - 08:31 am
Merck
AstraZeneca
cancer
Scientists warn on "dead space" as pharma giants shun neuropsych
Fierce Biotech
Tue, 06/14/11 - 09:25 am
R&D
neuropsychology
GSK
AstraZeneca
AstraZeneca Pays $250K For Sex Discrimination
Pharmalot
Mon, 06/6/11 - 09:35 pm
gender discrimination
AstraZeneca
Drugmakers Face Patent Cliff Generics
Yahoo/InvestorsBusinessDaily
Wed, 06/1/11 - 07:46 am
patents
generics
GSK
Bristol-Myers Squibb
AstraZeneca
Pfizer
Eli Lilly
Merck
Forest Labs
Teva Pharmaceuticals
Abbott Laboratories
7 Dividend Winners in Big Pharma
Seeking Alpha
Tue, 05/31/11 - 10:56 am
Abbott Laboratories
AstraZeneca
GSK
dividends
JNJ
Merck
Novartis
Pfizer
Pages
« first
‹ previous
…
134
135
136
137
138
139
140
141
142
…
next ›
last »